Boston Scientific | BSX - Betriebsergebnis

Aktienkurs
59.00
Täglich Wechseln
-0.95 -1.58%
Monatlich
-6.25%
Jährlich
-42.57%
Q2 Prognose
60.74




Betriebsergebnis Veränderung Datum
Abbott USD 1.85B 399M 2026-03
AtriCure USD 2.49M 2.28M 2025-12
Avanos Medical USD 24.77M 5.8M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.05B 190M 2026-03
CONMED USD 36.62M 24.74M 2025-12
Cooper Companies USD 212.8M 72.4M 2025-12
Danaher USD 1.34B 158M 2026-03
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Globus Medical USD 181.31M 298.83M 2025-12
Illumina USD 256M 6M 2025-12
Inogen USD -7.79M 728K 2024-09
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 859.7M 5.6M 2026-03
J&J USD 6.62B 1.03B 2026-03
Masimo USD 83.9M 300K 2025-12
Medtronic USD 1.74B 40M 2025-12
Merit Medical Systems USD 54.2M 11.58M 2025-12
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 445.24M 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12